UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

15 Management of cardiovascular involvement in SLE

Lupus science & medicine, 2023-09, Vol.10 (Suppl 2), p.A8-A8

Espinosa, Gerard

2023

Volltextzugriff (PDF)

Current treatment of antiphospholipid syndrome: lights and shadows

Nature reviews. Rheumatology, 2015-10, Vol.11 (10), p.586-596

2015

Volltextzugriff (PDF)

Crime and Inequality in Academic Achievement Across School Districts in the United States

Demography, 2020-02, Vol.57 (1), p.123-145

Torrats-Espinosa, Gerard

2020

Volltextzugriff (PDF)

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

Journal of autoimmunity, 2018-08, Vol.92, p.1-11

2018

Volltextzugriff (PDF)

Violence and Vigilance: The Acute Effects of Community Violent Crime on Sleep and Cortisol

Child development, 2018-07, Vol.89 (4), p.e323-e331

2018

Volltextzugriff (PDF)

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry

Autoimmunity reviews, 2016-12, Vol.15 (12), p.1120-1124

2016

Volltextzugriff (PDF)

Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy

International journal of molecular sciences, 2022-04, Vol.23 (9), p.4946

2022

Volltextzugriff (PDF)

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”

Autoimmunity reviews, 2022-04, Vol.21 (4), p.103055, Article 103055

2022

Volltextzugriff (PDF)

Catastrophic antiphospholipid syndrome: Updated diagnostic algorithms

Autoimmunity reviews, 2010-12, Vol.10 (2), p.74-79

2010

Volltextzugriff (PDF)

Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab

Autoimmunity reviews, 2013-09, Vol.12 (11), p.1085-1090

2013

Volltextzugriff (PDF)

Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide

Frontiers in immunology, 2020-06, Vol.11, p.865-865

2020

Volltextzugriff (PDF)

14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

Autoimmunity reviews, 2014-07, Vol.13 (7), p.699-707

2014

Volltextzugriff (PDF)

TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA

Retina (Philadelphia, Pa.), 2018-07, Vol.38 (7), p.1361-1370

2018

Volltextzugriff (PDF)

Antiphospholipid Syndrome in Systemic Autoimmune Diseases

Second edition., 2016

Volltextzugriff (PDF)

Immunosuppression and Chagas disease: a management challenge

PLoS neglected tropical diseases, 2013-01, Vol.7 (1), p.e1965

2013

Volltextzugriff (PDF)

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Respiratory research, 2022-02, Vol.23 (1), p.37-10, Article 37

2022

Volltextzugriff (PDF)

Using machine learning to estimate the effect of racial segregation on COVID-19 mortality in the United States

Proceedings of the National Academy of Sciences - PNAS, 2021-02, Vol.118 (7)

Torrats-Espinosa, Gerard

2021

Volltextzugriff (PDF)

Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization

Acta ophthalmologica (Oxford, England), 2015-09, Vol.93 (6), p.561-567

2015

Volltextzugriff (PDF)

Management of refractory cases of catastrophic antiphospholipid syndrome

Autoimmunity reviews, 2011-09, Vol.10 (11), p.664-668

2011

Volltextzugriff (PDF)

Clinical Manifestations and Diagnosis of Behçet’s Syndrome

European medical journal. Rheumatology, 2021-07, p.94-104

2021

Volltextzugriff (PDF)

Placental damage in pregnancies with systemic lupus erythematosus: A narrative review

Frontiers in immunology, 2022-08, Vol.13, p.941586-941586

2022

Volltextzugriff (PDF)

Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study

Arthritis research & therapy, 2022-11, Vol.24 (1), p.253-8, Article 253

2022

Volltextzugriff (PDF)

Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center

Arthritis research & therapy, 2022-04, Vol.24 (1), p.91-91, Article 91

2022

Volltextzugriff (PDF)

Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry

Lupus, 2022-02, Vol.31 (2), p.194-201

2022

Volltextzugriff (PDF)

The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

Arthritis research & therapy, 2022-01, Vol.24 (1), p.9-9, Article 9

2022

Volltextzugriff (PDF)

1 – 25 von 538

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieRheumatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(452)
Mit Volltextzugriff
(412)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

15 Management of cardiovascular involvement in SLE

Current treatment of antiphospholipid syndrome: lights and shadows

Crime and Inequality in Academic Achievement Across School Districts in the United States

The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: A comprehensive review

Violence and Vigilance: The Acute Effects of Community Violent Crime on Sleep and Cortisol

Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry

Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”

Catastrophic antiphospholipid syndrome: Updated diagnostic algorithms

Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab

Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide

14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome

TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA

Antiphospholipid Syndrome in Systemic Autoimmune Diseases

Immunosuppression and Chagas disease: a management challenge

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge

Using machine learning to estimate the effect of racial segregation on COVID-19 mortality in the United States

Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization

Management of refractory cases of catastrophic antiphospholipid syndrome

Clinical Manifestations and Diagnosis of Behçet’s Syndrome

Placental damage in pregnancies with systemic lupus erythematosus: A narrative review

Accrual of organ damage in Behçet's syndrome: trajectory, associated factors, and impact on patients' quality of life over a 2-year prospective follow-up study

Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center

Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry

The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

Aktive Filter

Suchergebnisse filtern